Patients with depression less likely to follow critical medication plan following heart procedure

United Kingdom News News

Patients with depression less likely to follow critical medication plan following heart procedure
United Kingdom Latest News,United Kingdom Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Patients with depression less likely to follow critical medication plan following heart procedure JAMA_current jamanetworkopen

Prior research has found that patients with depression have up to a three-fold increased risk of health problems or death after a heart attack than those without depression.

"It is well-appreciated that depression carries adverse cardiovascular risk. We wanted to understand better why that is the case," said Jared W. Magnani, M.D., M.Sc., UPMC cardiologist and associate professor of medicine at Pitt."We found that 10%-20% of individuals with depression were less likely to take their medicine after PCI—which is significant—because this group is at a higher risk for serious complications or dying from a heart attack.

The study examined the records of more than 124,000 patients who underwent PCI and were diagnosed with depression by a medical provider. Magnani and his team used medical claims data that incorporated prescriptions filled at pharmacies to track if patients kept up with prescriptions.adherence is a critical component of cardiovascular disease prevention—but it is complex.

Magnani suggests that providers incorporate depression screenings to develop ways to improve medication adherence and

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

United Kingdom Latest News, United Kingdom Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Maya Jama enjoys dates with US R&B singer after getting cosy at celeb hotspotMaya Jama enjoys dates with US R&B singer after getting cosy at celeb hotspotTELLY beauty Maya Jama has been enjoying cosy nights out with an R&B singer. The new Love Island host, 28, was pictured with US star Giveon twice this week — but he did his best to hide from th…
Read more »

Love Island host Maya Jama 'enjoying cosy dates with R&B singer Giveon'Love Island host Maya Jama 'enjoying cosy dates with R&B singer Giveon'Maya Jama is thought to be dating someone new, in the form of US singer Giveon - who most famously collaborated on hit song Peaches with Justin Bieber, which was No.1 worldwide
Read more »

Jailed pervert doctor faces losing medical licence after abusing 48 patientsJailed pervert doctor faces losing medical licence after abusing 48 patientsKrishna Singh, 72, is currently behind bars after sexually abusing 48 female patients over the course of 35 years. A date has now been set for a hearing by the Medical Practitioners Tribunal Service.
Read more »

Glasgow hospital patients to be 'Home for Lunch' in new discharge initiativeGlasgow hospital patients to be 'Home for Lunch' in new discharge initiativeFamilies are being asked to make sure appropriate arrangements are in place to get their loved ones out of the hospital before 12pm as the health board launches a new 'Home for Lunch' campaign.
Read more »

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial showsThree-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial showsA three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remission in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.
Read more »

Experimental cancer therapy shows success in more than 70% of patients in global clinical trialsExperimental cancer therapy shows success in more than 70% of patients in global clinical trialsA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
Read more »



Render Time: 2025-02-23 04:30:04